Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
FAQ
Smoking is a common habit linked to numerous health risks, affecting multiple body systems and increasing various disease risks, including respiratory and cardiovascular issues. It also triggers inflammatory reactions by affecting the immune system with harmful tobacco chemicals like nicotine and polycyclic aromatic hydrocarbons.
Smoking's impact on autoimmune skin conditions varies; it typically worsens diseases like psoriasis and hidradenitis suppurativa but shows mixed effects on others like pemphigus vulgaris and Behçet’s disease, where symptoms sometimes decrease in smokers. Interestingly, conditions like Parkinson’s disease and ulcerative colitis also show reduced associations with smoking.
A specific study noted that current smokers had a surprisingly reduced risk of developing vitiligo, a condition involving the loss of skin pigmentation due to melanocyte destruction. This could be related to tobacco’s inhibitory effects on monoamine oxidase (MAO), although further research is needed to clarify this mechanism.
Despite some findings suggesting protective effects against certain conditions, the overall negative health impacts of smoking far outweigh these benefits. Therefore, smoking should not be considered a preventive or therapeutic measure for vitiligo or any other health condition.
Suggested reading:
FAQOther Questions
- How long does it take to treat vitiligo?
Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...
- What is vitiligo?
Vitiligo (pronounced vit-ill-EYE-go) is a generally unpredictable skin disease that causes a gradual loss of skin color and overlying hair on different parts of the body. Cont...
- Who is prone to vitiligo?
Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.